Cubist Systematic Strategies’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-869
| Closed | -$16.2K | – | 2425 |
|
|
2024
Q3 | $16.2K | Sell |
869
-1,297
| -60% | -$24.1K | ﹤0.01% | 1332 |
|
|
2024
Q2 | $36K | Buy |
2,166
+1,308
| +152% | +$21.8K | ﹤0.01% | 1256 |
|
|
2024
Q1 | $14.9K | Sell |
858
-307
| -26% | -$5.33K | ﹤0.01% | 2018 |
|
|
2023
Q4 | $18.2K | Buy |
1,165
+577
| +98% | +$9.02K | ﹤0.01% | 1943 |
|
|
2023
Q3 | $29.1K | Buy |
588
+33
| +6% | +$1.63K | ﹤0.01% | 1744 |
|
|
2023
Q2 | $43.4K | Buy |
555
+536
| +2,821% | +$41.9K | ﹤0.01% | 1920 |
|
|
2023
Q1 | $1.76K | Sell |
19
-1,138
| -98% | -$105K | ﹤0.01% | 2751 |
|
|
2022
Q4 | $136K | Sell |
1,157
-721
| -38% | -$85K | ﹤0.01% | 2779 |
|
|
2022
Q3 | $341K | Buy |
1,878
+392
| +26% | +$71.2K | ﹤0.01% | 2722 |
|
|
2022
Q2 | $133K | Buy |
1,486
+304
| +26% | +$27.2K | ﹤0.01% | 3332 |
|
|
2022
Q1 | $183K | Buy |
1,182
+255
| +28% | +$39.5K | ﹤0.01% | 3057 |
|
|
2021
Q4 | $276K | Buy |
927
+165
| +22% | +$49.1K | ﹤0.01% | 2851 |
|
|
2021
Q3 | $439K | Sell |
762
-441
| -37% | -$254K | 0.01% | 2124 |
|
|
2021
Q2 | $546K | Sell |
1,203
-1,333
| -53% | -$605K | 0.01% | 1951 |
|
|
2021
Q1 | $1.37M | Buy |
+2,536
| New | +$1.37M | 0.02% | 1311 |
|